203 related articles for article (PubMed ID: 22426498)
21. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
[TBL] [Abstract][Full Text] [Related]
22. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?
Leslie WD; Morin SN; Lix LM; Majumdar SR
Osteoporos Int; 2014 Dec; 25(12):2817-24. PubMed ID: 25092059
[TBL] [Abstract][Full Text] [Related]
23. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
Yu R; Leung J; Woo J
J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
[TBL] [Abstract][Full Text] [Related]
24. Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW).
Compston JE; Flahive J; Hooven FH; Anderson FA; Adachi JD; Boonen S; Chapurlat RD; Cooper C; Díez-Perez A; Greenspan SL; LaCroix AZ; Lindsay R; Netelenbos JC; Pfeilschifter J; Roux C; Saag KG; Silverman S; Siris ES; Watts NB; Gehlbach SH;
Calcif Tissue Int; 2014 Feb; 94(2):223-31. PubMed ID: 24077896
[TBL] [Abstract][Full Text] [Related]
25. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study.
Samelson EJ; Broe KE; Xu H; Yang L; Boyd S; Biver E; Szulc P; Adachi J; Amin S; Atkinson E; Berger C; Burt L; Chapurlat R; Chevalley T; Ferrari S; Goltzman D; Hanley DA; Hannan MT; Khosla S; Liu CT; Lorentzon M; Mellstrom D; Merle B; Nethander M; Rizzoli R; Sornay-Rendu E; Van Rietbergen B; Sundh D; Wong AKO; Ohlsson C; Demissie S; Kiel DP; Bouxsein ML
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):34-43. PubMed ID: 30503163
[TBL] [Abstract][Full Text] [Related]
26. clinical risk factors for osteoporosis in Ireland and the UK: a comparison of FRAX and QFractureScores.
Cummins NM; Poku EK; Towler MR; O'Driscoll OM; Ralston SH
Calcif Tissue Int; 2011 Aug; 89(2):172-7. PubMed ID: 21647704
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Vertebral, Hip, and Femoral Fractures Among Patients With Parkinson's Disease: A 5-Year Follow-up in Korea.
Park SB; Chung CK; Lee JY; Lee JY; Kim J
J Am Med Dir Assoc; 2019 May; 20(5):617-623. PubMed ID: 30366761
[TBL] [Abstract][Full Text] [Related]
28. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.
McCloskey EV; Johansson H; Oden A; Austin M; Siris E; Wang A; Lewiecki EM; Lorenc R; Libanati C; Kanis JA
J Bone Miner Res; 2012 Jul; 27(7):1480-6. PubMed ID: 22431426
[TBL] [Abstract][Full Text] [Related]
29. Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study.
Akyea RK; McKeever TM; Gibson J; Scullion JE; Bolton CE
BMJ Open; 2019 Apr; 9(4):e024951. PubMed ID: 30948576
[TBL] [Abstract][Full Text] [Related]
30. Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women's Health Initiative Study.
Crandall CJ; Larson J; LaCroix A; Cauley JA; LeBoff MS; Li W; LeBlanc ES; Edwards BJ; Manson JE; Ensrud K
J Gen Intern Med; 2019 Feb; 34(2):235-242. PubMed ID: 30334182
[TBL] [Abstract][Full Text] [Related]
31. Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women.
Liu S; Chen R; Ding N; Wang Q; Huang M; Liu H; Xie Z; Ou Y; Sheng Z
J Endocrinol Invest; 2021 Feb; 44(2):347-352. PubMed ID: 32495298
[TBL] [Abstract][Full Text] [Related]
32. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Kanis JA; Johansson H; Oden A; McCloskey EV
Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.
Borgström F; Ström O; Kleman M; McCloskey E; Johansson H; Odén A; Kanis JA
Osteoporos Int; 2011 Mar; 22(3):955-65. PubMed ID: 20532482
[TBL] [Abstract][Full Text] [Related]
34. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
[TBL] [Abstract][Full Text] [Related]
35. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
[TBL] [Abstract][Full Text] [Related]
36. Association between post-stroke disability and 5-year hip-fracture risk: The Women's Health Initiative.
Northuis CA; Crandall CJ; Margolis KL; Diem SJ; Ensrud KE; Lakshminarayan K
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104976. PubMed ID: 32689623
[TBL] [Abstract][Full Text] [Related]
37. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
38. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
[TBL] [Abstract][Full Text] [Related]
39. Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Watts NB;
Nat Rev Endocrinol; 2014 Jul; 10(7):412-22. PubMed ID: 24751880
[TBL] [Abstract][Full Text] [Related]
40. Association between hand-grip strength and site-specific risks of major osteoporotic fracture: Results from the Japanese Population-based Osteoporosis Cohort Study.
Kamiya K; Kajita E; Tachiki T; Ikehara S; Kouda K; Sato Y; Tamaki J; Kagamimori S; Iki M
Maturitas; 2019 Dec; 130():13-20. PubMed ID: 31706431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
